Literature DB >> 23027045

Designing functional siRNA with reduced off-target effects.

Yuki Naito1, Kumiko Ui-Tei.   

Abstract

RNA interference (RNAi) mediated by small interfering RNA (siRNA) is now widely used to knock down gene expression in a sequence-specific manner, making it a powerful tool not only for studying gene functions but also for therapeutic applications. siRNA decreases the expression level of the intended target gene with complete complementarity by cleaving its mRNA. However, the efficacy of each siRNA widely varies depending on its sequence in mammalian cells; only a limited fraction of randomly designed siRNAs is functional. Moreover, off-target silencing effects arise when the siRNA has partial complementarity in the seed region with unintended genes. Here, we describe the rational designing of functional, off-target effect-reduced siRNAs using siDirect 2.0 Web server (http://siDirect2.RNAi.jp/). By using the default parameters, siDirect 2.0 can design at least one qualified siRNA for >94% of human mRNA sequences in the RefSeq database.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23027045     DOI: 10.1007/978-1-62703-119-6_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

Review 1.  Preclinical and clinical development of siRNA-based therapeutics.

Authors:  Gulnihal Ozcan; Bulent Ozpolat; Robert L Coleman; Anil K Sood; Gabriel Lopez-Berestein
Journal:  Adv Drug Deliv Rev       Date:  2015-02-07       Impact factor: 15.470

Review 2.  Recent advances in RNA interference therapeutics for CNS diseases.

Authors:  Pavitra S Ramachandran; Megan S Keiser; Beverly L Davidson
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

3.  Involvement of Gβγ subunits of Gi protein coupled with S1P receptor on multivesicular endosomes in F-actin formation and cargo sorting into exosomes.

Authors:  Taketoshi Kajimoto; Nesma Nabil Ibrahim Mohamed; Shaymaa Mohamed Mohamed Badawy; Shubi Ambwene Matovelo; Mitsuhiro Hirase; Shunsuke Nakamura; Daisuke Yoshida; Taro Okada; Takeshi Ijuin; Shun-Ichi Nakamura
Journal:  J Biol Chem       Date:  2017-11-13       Impact factor: 5.157

4.  Characterization and use of Equine Bone Marrow Mesenchymal Stem Cells in Equine Cartilage Engineering. Study of their Hyaline Cartilage Forming Potential when Cultured under Hypoxia within a Biomaterial in the Presence of BMP-2 and TGF-ß1.

Authors:  Thomas Branly; Lélia Bertoni; Romain Contentin; Rodolphe Rakic; Tangni Gomez-Leduc; Mélanie Desancé; Magalie Hervieu; Florence Legendre; Sandrine Jacquet; Fabrice Audigié; Jean-Marie Denoix; Magali Demoor; Philippe Galéra
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

5.  Protein kinase D1 deficiency promotes differentiation in epidermal keratinocytes.

Authors:  Vivek Choudhary; Lawrence O Olala; Ismail Kaddour-Djebbar; Inas Helwa; Wendy B Bollag
Journal:  J Dermatol Sci       Date:  2014-10-02       Impact factor: 4.563

6.  RNA therapeutics: RNAi and antisense mechanisms and clinical applications.

Authors:  Jessica Chery
Journal:  Postdoc J       Date:  2016-07

7.  Discovery of a dicer-independent, cell-type dependent alternate targeting sequence generator: implications in gene silencing & pooled RNAi screens.

Authors:  Bhavneet Bhinder; David Shum; Mu Li; Glorymar Ibáñez; Alexander V Vlassov; Susan Magdaleno; Hakim Djaballah
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

Review 8.  From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies.

Authors:  Hironori Adachi; Martin Hengesbach; Yi-Tao Yu; Pedro Morais
Journal:  Biomedicines       Date:  2021-05-14

Review 9.  siRNA Versus miRNA as Therapeutics for Gene Silencing.

Authors:  Jenny K W Lam; Michael Y T Chow; Yu Zhang; Susan W S Leung
Journal:  Mol Ther Nucleic Acids       Date:  2015-09-15       Impact factor: 10.183

10.  Validation of RNAi Silencing Efficiency Using Gene Array Data shows 18.5% Failure Rate across 429 Independent Experiments.

Authors:  Gyöngyi Munkácsy; Zsófia Sztupinszki; Péter Herman; Bence Bán; Zsófia Pénzváltó; Nóra Szarvas; Balázs Győrffy
Journal:  Mol Ther Nucleic Acids       Date:  2016-09-27       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.